Dr. Bruce Boyttle, the Nobel laureate in medicine, and Javier Romero Ledesma, a private equity investor based in Shanghai, co-founded a biotechnology company to find all genes related to life extension and anti-aging, with a view to increasing human life expectancy to 160 years.
As a well-known immunologist and geneticist in the United States, Dr. Bruce Boyttle is currently the director of the Center for Host Defense Genetic Research at the Southwestern Medical Center and the Scripps Research Institute (TSRI) Genetics. Department head. Sharing the 2011 Shao Yifu Life Science and Medicine Award with Ruslan M. Zhetoff and Jul A. Aufman for discovering how to activate innate immunity. In the same year, Boyler and Jules A Hoffman were awarded the Nobel Prize in Physiology or Medicine to demonstrate their contribution to humanity in the “discovery of the activation of innate immune mechanismsâ€.
Mutagenesis Biotech's goal is to extend human life to 160 years old
Bruce Boyttle has been researching technology for identifying specific genes since he was at the University of California in 2000, and has been fully validated in continuous application.
Javier Romero, a private equity investor living in Shanghai, was concerned about Dr. Boitler's research and immediately became interested in technology. Later, Javier Romero contacted Dr. Bruce Boitler and conducted in-depth communication to reach a consensus. The two co-founded Mutagenesis Biotech in 2015, which will build a 70,000-square-meter genetic mutagenesis laboratory (the world's largest genetic mutagenesis laboratory) that will use Dr. Boitler's unique and reliable The technology screens the entire genome to find longevity and many other disease- and disease-related genes, with the goal of extending human life to more than 160 years of age within five years.
As Mr. Javier Romero said: “Our goal is not only to live to 160, but to delay aging in the same proportion, so our 80-year-old physical condition will be equivalent to the current 30 or 40.†The company plans Developed a life-extending therapy within 5 years.
Mutagenesis is also working to find genes related to the prevention and treatment of obesity, air toxicity (air pollution, smoking, etc.), diabetes, cancer and heart disease. Compared with the genes for longevity and anti-aging, it is shorter to identify such genes, and the corresponding therapies are expected to be developed within two years. At the same time, Mutagenesis is also working with a number of large companies (including Chinese companies) and pharmaceutical companies to develop various biotechnology research services in different ways to ensure the company's business diversity and effectiveness.
Our company specializes in providing Nootropics raw materials -Nootropics Nootropics Nootropics powder Nootropic Active Pharmaceutical Ingredients Nootropics peptides
We also provide Active Pharmaceutical Ingredients // Bodybuilding Peptide //Sarms and so on
Nootropics , Nootropics powder , Nootropic Active Pharmaceutical Ingredients , Nootropics peptides
XI AN RHINE BIOLOGICAL TECHNOLOGY CO.,LTD , https://www.rhinebioteches.com